Advertisement Fidelity
Home > Boards > US OTC > Medical - Drugs >

NorthWest Biotherapeutics (NWBO)

NWBO RSS Feed
Add NWBO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator TOB, Astavakra
Search This Board:
Last Post: 4/19/2014 11:42:19 PM - Followers: 141 - Board type: Free - Posts Today: 0


 

Corporate Profile

Northwest Biotherapeutics, Inc. is the premier development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products
that generate and enhance immune system responses to treat  various forms of Cancer.  www.nwbio.com

The Company operates in the United States and is incorporated in Delaware.

Company Contact IR:  investors@nwbio.com

Transfer Agent

BNYMellon Shareowner Services
520 Pike Street
Seattle, WA, 98101

Equity Holding customer service representatives are available from 9:00 a.m. to 7:00 p.m. Eastern Time,
Monday through Friday. Call +1 800 522 6645 (U.S. & Canada).

Holdings Summary
Shares Outstanding 162,806,546 a/o May 09, 2012
Shares Authorized 450,000,000 a/o Feb 2012
 







52-Week High - (02-June-11) .89
52-Week Low - (26-Apr-12) .16


Linda Powers Interview 6-25-11 5-15-12
Recent Press Releases and News for NWBO 
Patent information for NWBO

Northwest Biotherapeutics GBM Brain Cancer Survival Story of Bob Gibbs

Northwest Biotherapeutics GBM Brain Cancer Survival Story of Mark Pace
Northwest Biotherapeutics, GBM Brain Cancer Survival Story of Mike Gregoire

Article from SmithOnStocks that sums up Northwest Biotherapeutics past to present through July 2012


Excellent bio-pharm sites for DD:  Minyanville.com BioTuesdays.com braintumorbiotechsummit.org

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NWBO
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#7450  Sticky Note 4th Annual "Cancer Immunotherapy: A Long Awaited Reality" Conference TOB 03/28/14 12:50:56 PM
#9007   I looked up "Surrogate Endpoint". The term Doktornolittle 04/19/14 11:42:19 PM
#9006   Evaluate: Regarding Kristen who is hoping to raise enough Doktornolittle 04/19/14 10:56:27 PM
#9005   Good selections. Pyrrhonian 04/19/14 09:06:05 PM
#9004   http://jco.ascopubs.org/content/32/12/1277.full?ijkey=0474691db1bdae5a8b916390208050295e8a695d&k Evaluate 04/19/14 08:43:04 PM
#9003   Somehow I missed this ..... Evaluate 04/19/14 08:11:46 PM
#9002   I admit I do not know any details Evaluate 04/19/14 07:25:15 PM
#9001   Sure thing. Thanks for digging up yours. I Pyrrhonian 04/19/14 06:04:47 PM
#9000   Correct. You're referring to Al Musella of the Epictetus 04/19/14 06:03:08 PM
#8999   When I saw: "same method used in the Evaluate 04/19/14 05:37:49 PM
#8997   Thanks for the reference. That makes a lot MolBiol 04/19/14 04:43:53 PM
#8996   Here's an interesting study from UCLA & the Epictetus 04/19/14 04:31:04 PM
#8995   Can some one here in a fair , afford567 04/19/14 04:04:41 PM
#8994   It seems to me that the primary endpoint MolBiol 04/19/14 02:36:59 PM
#8993   Pyrr, thanks for reposting this. longusa 04/19/14 02:27:04 PM
#8992   DDRANTE@Twitter says minimum 75.00 Care100 04/19/14 01:05:42 PM
#8990   Question for the board. tuna8377 04/19/14 09:58:44 AM
#8989   Also pertinent is this: Pyrrhonian 04/19/14 05:00:13 AM
#8987   You mean 'enlarge' the trial? They're really two Pyrrhonian 04/19/14 04:06:21 AM
#8986   Can't wait to hear Pyrrhonian's perfectly logical explanation foxhound02 04/18/14 11:27:55 PM
#8985   Not sure I fully understand those regulations. Doktornolittle 04/18/14 09:57:06 PM
#8984   Ohhh, looks like longusa is keeping gold from Pyrrhonian 04/18/14 09:46:25 PM
#8983   Looking back, I think the name was Alexander77, Doktornolittle 04/18/14 09:34:59 PM
#8982   Sure thing, Dok. Yeah, I've gotten a lot Pyrrhonian 04/18/14 09:09:38 PM
#8981   Pyrrhonian: You will also encounter estimates about Doktornolittle 04/18/14 09:05:29 PM
#8980   Halting a trial not fully enrolled. Pyrrhonian 04/18/14 08:55:35 PM
#8979   Evaluate: That's a huge number of patients... Doktornolittle 04/18/14 07:22:37 PM
#8978   DCVax-L Model Positive on Primary Endpoint. Pyrrhonian 04/18/14 07:09:04 PM
#8977   Another difference between NW's tech and IMUC's: Pyrrhonian 04/18/14 06:28:06 PM
#8976   Oh, look at this: (note, anaplastic glioma) Pyrrhonian 04/18/14 05:15:35 PM
#8975   Ha.. Yeah bow ties are a little creepy. Pyrrhonian 04/18/14 05:03:35 PM
#8974   Link to NWBO? Zero evidence to follow up iclight 04/18/14 04:44:33 PM
#8973   Fantastic find Eval. Wow. Might another patent upgrade Pyrrhonian 04/18/14 04:23:05 PM
#8972   As seen at http://virtualtrials.com/Currently_Recruiting_Clinical_Trials_-_High_Grade_Glioma_treatm Evaluate 04/18/14 03:41:48 PM
#8971   Dentritic Cells Therapy at Medical Center Cologne Evaluate 04/18/14 02:43:18 PM
#8970   Hi Long, MolBiol 04/18/14 02:42:39 PM
#8969   Thks OU...now it is clear !!! no more rene33 04/18/14 02:29:32 PM
#8968   Hope you are right Pyrr! StockFollower 04/18/14 02:29:02 PM
#8967   Thanks again Mol. Heavy on the science longusa 04/18/14 02:18:18 PM
#8966   I'm telling you guys, this is a Greek Pyrrhonian 04/18/14 02:06:37 PM
#8965   I have. Great run down. Some time ago, Pyrrhonian 04/18/14 01:36:26 PM
#8964   No, the FDA doesn't decide what goes on ou71764 04/18/14 12:18:36 PM
#8963   Lol, no afford, no one's making anything up. Pyrrhonian 04/18/14 11:50:01 AM
#8962   Thks,,,so the FDA controls the uses of DCvax rene33 04/18/14 11:32:26 AM
#8961   This is what I am not getting. You afford567 04/18/14 11:22:47 AM
#8960   I assume that most of you have read inveterate 04/18/14 11:20:42 AM
#8959   He mentioned having attended one "like this" before, Pyrrhonian 04/18/14 11:13:34 AM
#8958   rene, I believe the FDA discuourages publicity around ou71764 04/18/14 10:49:51 AM
#8957   appreciate your reply dok !!!hope others address the rene33 04/18/14 10:41:28 AM
#8956   Simultaneous release of a newswire along with a Doktornolittle 04/18/14 10:39:50 AM
#8955   Rene: I don't know about the stats Doktornolittle 04/18/14 10:23:05 AM
PostSubject